AstraZeneca's COVID-19 drug cocktail meets main goal in late-stage trial


Reuters | Updated: 11-10-2021 12:07 IST | Created: 11-10-2021 12:06 IST
AstraZeneca's COVID-19 drug cocktail meets main goal in late-stage trial
Representative Image Image Credit: Flickr

AstraZeneca said on Monday its antibody cocktail, the first protective shot other than vaccines against COVID-19, met its main goals in a late-stage trial, helping reduce severe COVID-19 or death in non-hospitalised patients.

Also Read: Small study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 vaccine mix

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback